[go: up one dir, main page]

UY38470A - COMPOUNDS AND COMPOSITIONS TO TREAT CONDITIONS ASSOCIATED WITH THE ACTIVITY OF NLRP - Google Patents

COMPOUNDS AND COMPOSITIONS TO TREAT CONDITIONS ASSOCIATED WITH THE ACTIVITY OF NLRP

Info

Publication number
UY38470A
UY38470A UY0001038470A UY38470A UY38470A UY 38470 A UY38470 A UY 38470A UY 0001038470 A UY0001038470 A UY 0001038470A UY 38470 A UY38470 A UY 38470A UY 38470 A UY38470 A UY 38470A
Authority
UY
Uruguay
Prior art keywords
compounds
nlrp
compositions
activity
conditions associated
Prior art date
Application number
UY0001038470A
Other languages
Spanish (es)
Inventor
Shomir Ghosh
Gary Glick
Jason Katz
William Roush
Hans Martin Seidel
Dong-Ming Shen
Shankar Venkatraman
Original Assignee
Novartis Inflammasome Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Inflammasome Res Inc filed Critical Novartis Inflammasome Res Inc
Publication of UY38470A publication Critical patent/UY38470A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

En un aspecto, se proveen compuestos de la Fórmula AA, o una sal farmacéuticamente aceptable de los mismos: en donde las variables indicadas en la Fórmula AA pueden ser las definidas en cualquier otra sección de la presente.In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are provided: wherein the variables set forth in Formula AA may be those defined elsewhere herein.

UY0001038470A 2018-11-13 2019-11-13 COMPOUNDS AND COMPOSITIONS TO TREAT CONDITIONS ASSOCIATED WITH THE ACTIVITY OF NLRP UY38470A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862760209P 2018-11-13 2018-11-13
US201862768811P 2018-11-16 2018-11-16
US201962795919P 2019-01-23 2019-01-23
US201962836577P 2019-04-19 2019-04-19
US201962895595P 2019-09-04 2019-09-04

Publications (1)

Publication Number Publication Date
UY38470A true UY38470A (en) 2020-06-30

Family

ID=72428109

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001038470A UY38470A (en) 2018-11-13 2019-11-13 COMPOUNDS AND COMPOSITIONS TO TREAT CONDITIONS ASSOCIATED WITH THE ACTIVITY OF NLRP

Country Status (1)

Country Link
UY (1) UY38470A (en)

Similar Documents

Publication Publication Date Title
ECSP20005581A (en) COMPOUNDS AND COMPOSITIONS TO TREAT CONDITIONS ASSOCIATED WITH NLRP ACTIVITY
CL2021001228A1 (en) Compounds and compositions for the treatment of conditions associated with nlrp activity
CO2018013293A2 (en) Pyrazolopyrimidine derivatives as a kinase inhibitor
CL2017001533A1 (en) Heterocyclic derivatives with sulfur-containing substituents active as pesticides
CL2017001017A1 (en) New methyl piperidine compounds useful for inhibiting microsomal e2 prostaglandin synthase-1
DOP2016000291A (en) COMPOSITIONS AND METHODS TO MODULATE THE EXPRESSION OF COMPLEMENT FACTOR B
EA201691194A1 (en) RHC STIMULATORS
EA201790923A1 (en) DERIVATIVES OF BETULINA
CU20140072A7 (en) DERIVATIVES OF DIHIDRO-OXAZINA AND DIHIDRO-PIRIDO-OXAZINA
CL2019002574A1 (en) Modulators of pcsk9 expression.
MX346730B (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF PULMONARY HYPERTENSION.
UY36257A (en) "IMIDAZOPIRIDAZINE COMPOUNDS".
CL2017000845A1 (en) Lysine Gingipain Inhibitors
MX2018013164A (en) Novel substituted imidazopyridine compounds as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan-2,3-dioxygenase.
MX2022000845A (en) INHIBITOR COMPOUNDS.
MX2020003732A (en) FUSIONED RING DERIVATIVE AS AN A2A RECEPTOR INHIBITOR.
MX2019013291A (en) COMPOUNDS AND METHODS TO TREAT BACTERIAL INFECTIONS.
EA201792264A1 (en) METHODS OF TREATING INFLAMMATORY DISEASES
MX2022002838A (en) AROMATIC HETEROCYCLIC COMPOUND THAT HAS A TRICYCLIC STRUCTURE, AND METHOD OF PREPARATION AND APPLICATION THEREOF.
CO2019007836A2 (en) Pyrrolotriazine derivatives as a kinase inhibitor
UY38470A (en) COMPOUNDS AND COMPOSITIONS TO TREAT CONDITIONS ASSOCIATED WITH THE ACTIVITY OF NLRP
CL2020000586A1 (en) Modulators of enac expression.
EA201690236A1 (en) INDOL-3-CARBINOLA DERIVATIVES
EA202191335A1 (en) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH NLRP ACTIVITY
DOP2021000090A (en) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH THE ACTIVITY OF NLRP